Alhadrami, H.A.; Burgio, G.; Thissera, B.; Orfali, R.; Jiffri, S.E.; Yaseen, M.; Sayed, A.M.; Rateb, M.E.
Neoechinulin A as a Promising SARS-CoV-2 Mpro Inhibitor: In Vitro and In Silico Study Showing the Ability of Simulations in Discerning Active from Inactive Enzyme Inhibitors. Mar. Drugs 2022, 20, 163.
https://doi.org/10.3390/md20030163
AMA Style
Alhadrami HA, Burgio G, Thissera B, Orfali R, Jiffri SE, Yaseen M, Sayed AM, Rateb ME.
Neoechinulin A as a Promising SARS-CoV-2 Mpro Inhibitor: In Vitro and In Silico Study Showing the Ability of Simulations in Discerning Active from Inactive Enzyme Inhibitors. Marine Drugs. 2022; 20(3):163.
https://doi.org/10.3390/md20030163
Chicago/Turabian Style
Alhadrami, Hani A., Gaia Burgio, Bathini Thissera, Raha Orfali, Suzan E. Jiffri, Mohammed Yaseen, Ahmed M. Sayed, and Mostafa E. Rateb.
2022. "Neoechinulin A as a Promising SARS-CoV-2 Mpro Inhibitor: In Vitro and In Silico Study Showing the Ability of Simulations in Discerning Active from Inactive Enzyme Inhibitors" Marine Drugs 20, no. 3: 163.
https://doi.org/10.3390/md20030163
APA Style
Alhadrami, H. A., Burgio, G., Thissera, B., Orfali, R., Jiffri, S. E., Yaseen, M., Sayed, A. M., & Rateb, M. E.
(2022). Neoechinulin A as a Promising SARS-CoV-2 Mpro Inhibitor: In Vitro and In Silico Study Showing the Ability of Simulations in Discerning Active from Inactive Enzyme Inhibitors. Marine Drugs, 20(3), 163.
https://doi.org/10.3390/md20030163
